Methods of Treating Cancer by Using HEATR1 as a Biomarker.

Technology #2015-311

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Categories
Researchers
Zhenkun Lou Ph.D.
Tongzheng Liu Ph.D.
Managed By
Tim D. Argo
Patent Protection
US Patent Pending
US Patent Pending

Mayo Clinic has discovered that HEATR1 is a novel Akt regulator and a predictor for chemoradioresistance.